MedTrace Logo

Measuring Lung Mechanics in Patients with COPD Using the REOM Handheld Portable Device

NCT05913323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2024-09-26

No results posted yet for this study

Summary

The purpose the study is to determine the agreement between the information obtained about lung mechanics (lung function) from the Rapid Expiratory Occlusion Monitor (REOM) handheld portable device with that obtained by conventional oscillometry as well as by pulmonary function testing (PFT), in patients with both 'mild' as well as 'very severe' forms of chronic obstructive pulmonary disease (COPD). This study also intends to study the user experience with this handheld portable device.

Conditions

Interventions

DEVICE

Rapid Expiratory Occlusion Monitor (REOM)

Device for which Health Canada approval (ITA Authorization) has been obtained for use in the present study.

DIAGNOSTIC_TEST

Standard oscillometry

tremoflo device-100, Thorasys Thoracic Medical Systems Inc., Montreal, Canada

DIAGNOSTIC_TEST

Standard pulmonary function test

Standard-of-care respiratory test.

Sponsors & Collaborators

  • McGill University

    collaborator OTHER

  • Thorasys Thoracic Medical Systems Inc.

    collaborator INDUSTRY

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-08-06
Completion
2024-08-06

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913323 on ClinicalTrials.gov